Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Operating Expenses | 7,809 | 7,091 | 7,841 | 6,980 | 9,166 |
Operating Income | -7,809 | -7,091 | -7,841 | -6,980 | -9,166 |
Interest Expense | 566 | 784 | 548 | 548 | 554 |
Other Income | 99 | 71 | -29 | 210 | -152 |
Pre-tax Income | -8,276 | -7,804 | -8,418 | -7,318 | -9,872 |
Net Income Continuous | -5,201 | -7,804 | -8,418 | -7,318 | -3,900 |
Net Income | $-5,201 | $-7,804 | $-8,418 | $-7,318 | $-3,900 |
EPS Basic Total Ops | -380.00 | -540.00 | -580.00 | -540.00 | -360.00 |
EPS Basic Continuous Ops | -358.96 | -542.81 | -585.72 | -545.59 | -343.78 |
EPS Diluted Total Ops | -380.00 | -540.00 | -580.00 | -540.00 | -360.00 |
EPS Diluted Continuous Ops | -358.96 | -542.81 | -585.72 | -545.59 | -343.78 |
EBITDA(a) | $-7,804 | $-7,086 | $-7,836 | $-6,976 | $-9,162 |